Blood Group Genotyping for Sickle Cell and Thalassaemia
Buyer: NHS England
- Published
- 5 December 2025
- Estimated value
- £140,671
- Procedure
- Direct award
- Lots
- 1
- Notice number
- 080318-2025
- Reference
- ocds-h6vhtk-05f01d
- Official source
- Official source
CPV codes
- 85100000Health services
Description
Embedding blood group genotyping into routine practice. The primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping
Awards
| Awarded to | Amount | Date |
|---|---|---|
| NHSBT | £140,671 | — |
Official publications
- FTS · 080318-2025 · 5 December 2025
Other tenders from NHS England
- Co-producing & evaluating interventions to support MMRV uptake Somali community
- NHS Chief Executive Readiness Assessment Model
- NHS Talking Therapies for Anxiety and Depression - RFI
- Chairs extended offer
- Soft Skills Course for GP IMGs (2026-2031)
- National Gambling Helpline
- Leadership Development to Support Engagement and Learning for Harmed Families
- Master’s Level Paediatric Audiology Modules Lot 2
- NHS National Framework for Lenvatinib
- Agenda for Change Job Evaluation Digital System
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is £140,671.
- Who is the buyer of this tender?
- The contracting authority is NHS England (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.